-
Tolvaptan, sold
under the
brand name
Samsca among others, is an
aquaretic drug that
functions as a selective,
competitive vasopressin receptor 2 (V2)...
- 2018,
Jynarque (
Tolvaptan) was
introduced as the
first FDA-approved
treatment for PKD. In a
recent long-term study,
patients using Tolvaptan had a 6.4% higher...
-
Tolvaptan phosphate is a drug used for the
treatment of
cardiac edema. It is a
prodrug of
tolvaptan,
formulated as the salt
tolvaptan sodium phosphate...
- Verbalis,
Joseph G.; Czerwiec,
Frank S.; Orlandi,
Cesare (2006-11-16). "
Tolvaptan, a
Selective Oral
Vasopressin V2-Receptor Antagonist, for Hyponatremia"...
- drug
tolvaptan for
ADPKD patients in the
beginning of 2015. The USA FDA
approved the use of
tolvaptan in the
treatment of
ADPKD in 2018.
Tolvaptan, an...
-
include conivaptan,
tolvaptan, demeclocycline, and
mozavaptan (OPC-31260), as well as lithium.
Conivaptan hydrochloride and
tolvaptan have been approved...
- (V3RA)
Nelivaptan V2
selective (V2RA)
Lixivaptan Mozavaptan Satavaptan Tolvaptan Somatostatin is a
competitive inhibitor. Demeclocycline, a tetracycline...
- by
clinical trials with
tolvaptan, a
vasopressin antagonist in the same drug
class as lixivaptan. In
clinical studies,
tolvaptan showed a
significant decrease...
- or
increasing the
protein intake. The
vasopressin receptor 2
blocker tolvaptan may also be used. The
presence of
cerebral edema, or
other moderate to...
-
colchicine alprazolam, oral midazolam, oral
triazolam felodipine, ranolazine,
tolvaptan,
eplerenone HMG-CoA
reductase inhibitors: lovastatin,
simvastatin ergot...
